Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Muhamad Ali Sk Abdul Kader"'
Autor:
Mohammed Ahmed Akkaif, Ahmad Naoras Bitar, Laith A. I. K. Al-Kaif, Nur Aizati Athirah Daud, Abubakar Sha’aban, Dzul Azri Mohamed Noor, Fatimatuzzahra’ Abd Aziz, Arturo Cesaro, Muhamad Ali SK Abdul Kader, Mohamed Jahangir Abdul Wahab, Chee Sin Khaw, Baharudin Ibrahim
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 9, Iss 9, p 307 (2022)
The global evolution of the SARS-CoV-2 virus is known to all. The diagnosis of SARS-CoV-2 pneumonia is expected to worsen, and mortality will be higher when combined with myocardial injury (MI). The combination of novel coronavirus infections in pati
Externí odkaz:
https://doaj.org/article/1343918596404b1d86d2bdacd4abf6f8
Autor:
Jack WC Tan, Derek P Chew, Muhamad Ali SK Abdul Kader, Junya Ako, Vinay K Bahl, Mark Chan, Kyung Woo Park, Praveen Chandra, I-Chang Hsieh, Do Quang Huan, Sofian Johar, Dafsah Arifa Juzar, Byeong-Keuk Kim, Cheol Whan Lee, Michael Kang-Yin Lee, Yi-Heng Li, Wael Almahmeed, Eric Oliver Sison, Doreen Tan, Yu-Chen Wang, Shiuan Jong Yeh, Gilles Montalescot
Publikováno v:
European Cardiology Review, Vol 16, Iss , Pp - (2021)
The unique characteristics of patients with acute coronary syndrome in the Asia-Pacific region mean that international guidelines on the use of dual antiplatelet therapy (DAPT) cannot be routinely applied to these populations. Newer generation P2Y12
Externí odkaz:
https://doaj.org/article/eabee3b36e394956b947e256170f156e
Autor:
Mohammed Ahmed Akkaif, Abubakar Sha’aban, Nur Aizati Athirah Daud, Ismaeel Yunusa, Mei Li Ng, Muhamad Ali Sk Abdul Kader, Dzul Azri Mohamed Noor, Baharudin Ibrahim
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 8, Iss 10, p 123 (2021)
Background: A new generation P2Y12 receptor inhibitor (ticagrelor) is recommended in current therapeutic guidelines to treat patients with coronary heart disease (CHD). However, it is unknown if ticagrelor is more effective than clopidogrel in elderl
Externí odkaz:
https://doaj.org/article/5169cca40eb5496a84a804c492e69e3b
Autor:
Mohammed Ahmed Akkaif, Nur Aizati Athirah Daud, Abubakar Sha’aban, Mei Li Ng, Muhamad Ali Sk Abdul Kader, Dzul Azri Mohamed Noor, Baharudin Ibrahim
Publikováno v:
Molecules, Vol 26, Iss 7, p 1987 (2021)
Clopidogrel is a widely-used antiplatelet drug. It is important for the treatment and prevention of coronary heart disease. Clopidogrel can effectively reduce platelet activity and therefore reduce stent thrombosis. However, some patients still have
Externí odkaz:
https://doaj.org/article/1468af7a633c400ca7d0d743dc135d64
Autor:
Arwa M. Amin, Lim Sheau Chin, Dzul Azri Mohamed Noor, Muhamad Ali SK Abdul Kader, Yuen Kah Hay, Baharudin Ibrahim
Publikováno v:
Cardiology Research and Practice, Vol 2017 (2017)
Dual antiplatelet therapy of aspirin and clopidogrel is pivotal for patients undergoing percutaneous coronary intervention. However, the variable platelets reactivity response to clopidogrel may lead to outcome failure and recurrence of cardiovascula
Externí odkaz:
https://doaj.org/article/f90581254e0b4605874d8caa78d7c056
Autor:
Adelyn Nisha Henry, Muhamad Ali SK Abdul Kader, Kumutha Gobal, Vicknesan Kulasingham, Gurudevan Mahadevan
Publikováno v:
Journal of the American College of Cardiology. 81:S243-S245
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a6b493439e7544ceec8aa5197f7334a
https://doi.org/10.1016/j.jacc.2023.03.244
https://doi.org/10.1016/j.jacc.2023.03.244
Publikováno v:
Journal of the American College of Cardiology. 79:S318-S321
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf41b784389867a1e81fdbd364706ec4
https://doi.org/10.1016/j.jacc.2022.03.269
https://doi.org/10.1016/j.jacc.2022.03.269
The no-reflow phenomenon is a complication of percutaneous coronary intervention resulting in poor myocardial perfusion and is associated with significant morbidity and mortality. It is vital for cardiologist to recognise this phenomenon as it is cli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36dc4d373e343e8c4e41f955fd7ae869
Autor:
Koon Wee Koay, Chong Aik Goh, Shahul Hamid Bin K A Ahmadsah, Poi Keong Kong, Muhamad Ali SK Abdul Kader
Publikováno v:
Journal of the American College of Cardiology. 79:S369-S371
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::779a850428c517eea6e077d042dd1d29
https://doi.org/10.1016/j.jacc.2022.03.297
https://doi.org/10.1016/j.jacc.2022.03.297
Autor:
Zhong Shiun Lee, Adriyawan Widya Nugraha, Shahul Hamid Bin K A Ahmadsah, Muhamad Ali SK Abdul Kader
Publikováno v:
Journal of the American College of Cardiology. 79:S110-S112
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8277a7a4c472edd3ca818e4df1e76beb
https://doi.org/10.1016/j.jacc.2022.03.152
https://doi.org/10.1016/j.jacc.2022.03.152